Multi-Symptom Assessment and Support for Cancer Care

描述（由申请人提供）：癌症患者通常会因其疾病或治疗毒性而出现多种症状和副作用。控制不良的症状和副作用严重影响患者的生活质量和功能；它们也可能干扰患者的依从性，限制剂量强度，并损害临床结果。第一阶段项目评估了Symptom FoneNet的可行性。Symptom FoneNet是一种支持互联网的计算机自动电话监控和严重程度警报系统，可以及早发现潜在的症状问题，向供应商发出警报，并加快干预速度。我们假设，定期的、计算机自动的多症状评估和实时症状严重程度警报将导致改善症状的结果。

DESCRIPTION (provided by applicant): Cancer patients commonly experience multiple symptoms and side effects due to their disease or the toxicities of treatment. Poorly controlled symptoms and side effects greatly impair patients' quality of life and ability to function; they may also interfere with patient compliance, limit dose intensities, and compromise clinical outcomes. This Phase I project evaluates the feasibility of Symptom FoneNet, an Internet-enabled, computer-automated telephone monitoring and severity alerting system that detects potential symptom problems early, alerts providers, and speeds intervention. We hypothesize that regular, computer-automated multi-symptom assessments and real-time symptom severity alerts will lead to improved symptom outcomes. Our specific aims in Phase I are to: 1. Assess nurses' and physicians' functional and usability needs, requirements, and preferences for incorporating Symptom FoneNet, a computer-automated multi-symptom symptom assessment and feedback alert system, into diverse community-based cancer care practices 2. Produce a working prototype of Symptom FoneNet, incorporating nurses' and physicians' requirements and preferences, for usability and acceptance testing with clinicians and patients 3. Evaluate cancer providers' ability and willingness to use the automated multi-symptom assessment and severity alerting system and to incorporate it into their community-based oncology practices 4. Evaluate cancer patients' ability and willingness to use the telephone-based system to self-report their cancer symptoms before, during, and after cancer therapy Phase I research will assess the usability and acceptance of Symptom FoneNet by patients and providers in community-based settings in Indiana, in collaboration with Community Cancer Care, Inc. (CCC). If feasibility is demonstrated in Phase I, we will complete product development and engineering and conduct a controlled field test in a Phase II study, also with CCC.